Clinical Research Directory
Browse clinical research sites, groups, and studies.
Assessing DCog Short for Neurotoxicity in CAR-T
Sponsor: Beth Israel Deaconess Medical Center
Summary
The aim of this study is to determine the effectiveness of DCog Short, a self-reporting, iPad-based application tool, in assessing neurotoxicity in participants undergoing CAR-T cell therapy.
Official title: Assessing the Performance of "DCog Short", an iPad-Based Tool for Neurotoxicity Evaluation in CAR-T Cell Therapy Patients: A Pilot Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2026-07
Completion Date
2027-08-31
Last Updated
2026-02-11
Healthy Volunteers
No
Conditions
Interventions
DCog Short
An iPad-based cognitive assessment instrument to evaluate neurotoxicity and consisting of a series of tests that measure various aspects of cognitive function. After hospital discharge, participants will be provided with iPads which will be returned at the 90 day follow up visit.
Locations (1)
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States